Vivos Therapeutics (VVOS) Earnings Date, Estimates & Call Transcripts → Have you heard of the $11 AI Coin? (From InvestorPlace) (Ad) Free VVOS Stock Alerts $2.04 -0.09 (-4.23%) (As of 03:36 PM ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateJun. 13EstimatedActual EPS (Mar. 28) -$3.05 Missed By -$3.05 Read Call TranscriptListen to Call Get Vivos Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for VVOS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVVOS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VVOS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceMillionaire investor and Republican donor makes surprising election predictionFind out who Louis believes is going to win the election... And why that will launch a second boom in AI stocksClick for his six specific AI stock in the crosshairs VVOS Earnings Date and InformationVivos Therapeutics last posted its earnings data on March 28th, 2024. The reported ($3.05) EPS for the quarter. The company earned $3.25 million during the quarter. Vivos Therapeutics has generated ($11.05) earnings per share over the last year (($11.05) diluted earnings per share). Vivos Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, June 13th, 2024 based off prior year's report dates.Read More Vivos Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 6/13/2024Estimated)------- 3/28/2024Q4 2023-($3.05)($3.05)($3.05)-$3.25 million 11/14/2023Q3 2023-($1.75)($1.75)($1.75)-$3.30 million8/16/2023Q2 2023($3.75)($3.75)-($0.12)$3.93 million$3.40 million 6/8/2023Q1 2023($4.25)($5.00)($0.75)($0.33)$3.71 million$3.86 million3/30/2023Q4 2022($5.50)($5.00)+$0.50($0.20)$4.01 million$3.95 million12/20/2022Q3 2022($6.25)($6.50)($0.25)($0.26)-$4.25 million Get the Latest News and Ratings for VVOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vivos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/16/2022Q1 2022($7.25)($6.50)+$0.75($0.26)$4.50 million$3.46 million3/31/2022Q4 2021-($8.50)($8.50)($0.34)$5.11 million$4.39 million11/15/2021Q3 2021($4.00)($6.50)($2.50)($0.26)$4.50 million$4.55 million 8/12/2021Q2 2021($4.50)($4.75)($0.25)($0.19)$3.70 million$4.50 million 5/17/2021Q1 2021($4.25)($4.75)($0.50)($0.19)$3.00 million$3.45 million Vivos Therapeutics Earnings - Frequently Asked Questions When is Vivos Therapeutics's earnings date? Vivos Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, June 13th, 2024 based off last year's report dates. Learn more on VVOS's earnings history. How can I listen to Vivos Therapeutics's earnings conference call? The conference call for Vivos Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Vivos Therapeutics's conference call transcript? The conference call transcript for Vivos Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Vivos Therapeutics generate each year? Vivos Therapeutics (NASDAQ:VVOS) has a recorded annual revenue of $13.80 million. How much profit does Vivos Therapeutics generate each year? Vivos Therapeutics (NASDAQ:VVOS) has a recorded net income of -$13.58 million. VVOS has generated -$11.05 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: VAPO Earnings Date INBS Earnings Date OSA Earnings Date AVGR Earnings Date NURO Earnings Date PSTV Earnings Date TMDIF Earnings Date VERO Earnings Date STSS Earnings Date AFIB Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:VVOS) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.